<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The risk of <z:hpo ids='HP_0001907'>thromboembolism</z:hpo> following cardioversion of <z:hpo ids='HP_0004749'>atrial flutter</z:hpo> (AFL) is considered low and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> treatment (ACT) is not recommended </plain></SENT>
<SENT sid="1" pm="."><plain>Nevertheless echocardiographic findings in patients with AFL and several case stories in literature suggest that the risk has been underestimated </plain></SENT>
<SENT sid="2" pm="."><plain>Two cases of <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e> are described after cardioversion of AFL in patients without concomitant ACT </plain></SENT>
<SENT sid="3" pm="."><plain>Until further studies are available the authors recommend that patients with AFL scheduled for cardioversion receive ACT according to the recommendations for <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> </plain></SENT>
</text></document>